Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-029351

Chief Financial Officer sold 12,400 shares at $8.75 ($108,500)

  • Chief Financial Officer acquired 12,400 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BLOCH KATHLEEN P. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-05-15 Exercise or conversion : show line 1 in the form +12,400 $4.69 $58,156 265,704 D
2018-05-15 Sale : show line 2 in the form −12,400 $8.75 $108,500 253,304 D
Open-market sales · 12,400 sh · avg $8.75 · $108,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-05-15 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −12,400 12,400 D
Loading xslF345X03/tv494429_4.xml…